Table 1.
Patients characteristics and outcomes.
| Patient# | Gender | Age(year) | BMI(kg/m2) | Disease | Lesion pattern | Total No. of screws | No ofscrews needing entry point drawing | Procedure time (min) | Fluoro scopy time (min) | Kerma Area Product (Gy.cm2) | TotalAir Kerma (mGy) | Concomitant procedure | Radiation therapy after fixation* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | F | 77 | 25..6 | LC | Lytic & cortical disruption | 3 | 2 | 103 | 10.77 | 184.53 | 532.62 | MWA | 1 |
| 2 | M | 55 | 27.5 | LC | Lytic & cortical disruption | 3 | 2 | 75 | 16.0 | 97.1 | 331.1 | Cryoablation | 0 |
| 3 | F | 59 | 26.6 | BC | Mixed | 3 | 2 | 64 | 12.7 | 65.8 | 260.4 | 0 | 0 |
| 4 | M | 73 | 18.6 | LC | Lytic | 1 | 1 | 27 | 4.4 | 16.9 | 67.9 | 0 | 1 |
| 5 | F | 69 | 22.1 | LC | Mixed | 2 | 1 | 80 | 15.1 | 78.8 | 278.7 | 0 | 0 |
| 6 | F | 62 | 28.4 | BC | Mixed | 4 | 1 | 101 | 26.6 | 174.4 | 607.7 | 0 | 1 |
| 7 | F | 56 | 22.8 | LC | Lytic & cortical disruption | 5 | 4 | 130 | 38.5 | 94.8 | 433.5 | MWA | 0 |
| 8 | F | 72 | 19.7 | LC | Lytic | 2 | 1 | 37 | 6.0 | 18.3 | 60.5 | 0 | 0 |
| 9 | F | 69 | 25.8 | CC & CRC | Lytic | 5 | 1 | 128 | 17.2 | 75.6 | 624.7 | 0 | 0 |
| 10 | F | 63 | 32.7 | OC | Mixed | 2 | 1 | 57 | 12.5 | 54.7 | 325.8 | 0 | 0 |
| 11 | M | 69 | 24.6 | LC | Mixed | 2 | 1 | 66 | 17.5 | 48.6 | 310.8 | 0 | 0 |
| 12 | F | 39 | 16.7 | BC | Mixed | 1 | 1 | 30 | 4.5 | 25.0 | 83.5 | 0 | 0 |
| 13 | M | 71 | 22.2 | CRC | Lytic & cortical disruption | 2 | 2 | 110 | 24.6 | 130.4 | 517.5 | 0 | 0 |
| 14 | F | 67 | 22.3 | BC | Blastic | 4 | 2 | 135 | 31.2 | 189.4 | 764.9 | 0 | 0 |
| 15 | F | 62 | 17.3 | LC | Mixed | 3 | 1 | 57 | 11.7 | 38.7 | 152.6 | 0 | 0 |
| 16 | M | 42 | 15.3 | LC | Lytic | 1 | 0 | 51 | 10.5 | 11.6 | 51.9 | RFA | 0 |
| 17 | M | 66 | 25.4 | LC | Lytic | 1 | 0 | 45 | 9.2 | 12.1 | 83.0 | RFA | 0 |
| 18 | M | 56 | 24.3 | HCC | Lytic | 1 | 0 | 233 | 10.8 | 46.0 | 204.2 | 0 | 1 |
| 19 | F | 49 | 24.5 | BC | Lytic | 2 | 0 | 39 | 4.3 | 20.5 | 123.6 | 0 | 1 |
| 20 | F | 74 | 22.5 | UC | Mixed | 2 | 1 | 110 | 24.6 | 130.4 | 517.5 | 0 | 1 |
| 21 | M | 71 | 21.1 | LC | Lytic | 2 | 0 | 39 | 8.4 | 56.0 | 274.4 | 0 | 0 |
| 22 | F | 65 | 18.4 | LC | Lytic & cortical disruption | 1 | 1 | 53 | 12.4 | 19.7 | 92.2 | MWA | 0 |
| 23 | F | 62 | 34.5 | LC | Lytic | 2 | 2 | 116 | 38.6 | 303.7 | 1111.5 | 0 | 0 |
| 24 | M | 55 | 24.6 | UC | Mixed | 2 | 2 | 45 | 5.7 | 50.2 | 173.3 | RFA | 0 |
| 25 | M | 56 | 32.3 | CRC | Mixed | 4 | 0 | 95 | 13.5 | 79.9 | 282.8 | 0 | 0 |
| 26 | F | 85 | 23.5 | EC | Lytic | 2 | 0 | 19 | 3.4 | 12.3 | 49.4 | 0 | 0 |
| 27 | M | 65 | 17.9 | LC | Lytic | 1 | 1 | 94 | 14.5 | 124.3 | 376.2 | MWA | 1 |
| 28 | M | 55 | 24.7 | LC | Lytic | 1 | 0 | 48 | 6.3 | 41.8 | 255.4 | 0 | 0 |
| 29 | F | 42 | 26.3 | BC | Lytic | 2 | 2 | 20 | 1.4 | 19.2 | 82.0 | 0 | 0 |
| 30 | F | 60 | 23.9 | CRC | Lytic | 1 | 0 | 46 | 8.5 | 27.5 | 203.3 | 0 | 0 |
| 31 | F | 89 | 22.3 | BC | Lytic | 2 | 0 | 52 | 7.1 | 45.2 | 210.2 | 0 | 0 |
| 32 | F | 56 | 25 | BC | Lytic & cortical disruption | 3 | 2 | 53 | 6.9 | 22.3 | 101.0 | 0 | 1 |
| 33 | F | 63 | 27.1 | EC | Lytic | 1 | 0 | 52 | 9.5 | 55.4 | 200.5 | 0 | 1 |
| 34 | F | 58 | 41.7 | BC | Lytic | 1 | 0 | 40 | 3.6 | 43.8 | 162.9 | 0 | 0 |
| 35 | F | 43 | 31.6 | LC | Mixed | 1 | 1 | 117 | 10.3 | 169.2 | 653.2 | MWA | 1 |
Note – BC: Breast carcinoma; BMI: Body mass index; CBCT: Cone beam computed tomography; CC: Cervical carcinoma; CRC: Colorectal carcinoma; EC: Endometrial carcinoma; F: Female; HCC: Hepatocellular carcinoma; KAP: Kerma area product; LC: Lung carcinoma; M: Male; MWA: Microwave ablation; OV: Ovarian carcinoma; RFA: Radiofrequency ablation; UC: Urothelial carcinoma.
*
1 indicates yes and 0 indicates no.